Neutrophils in Chronic Obstructive Pulmonary Disease: A Bibliometric Analysis of Trends and Themes.
Researchers
Qi Xiang, Ziyi Chen
Abstract
Inflammation is central to the pathophysiology of chronic obstructive pulmonary disease (COPD), and neutrophils are important effector cells in both stable disease and acute exacerbations. Although studies involving neutrophils and COPD have expanded, bibliometric evidence describing publication patterns, collaboration networks, and evolving themes in this literature remains limited. This study aimed to map the research landscape of COPD publications that address neutrophils using bibliometric methods. Publications indexed in the Science Citation Index Expanded and Social Sciences Citation Index of the Web of Science Core Collection from 1977 to 2024 were retrieved using topic terms for COPD and neutrophils. Only English-language original articles were included. Bibliometric analyses were performed in R using the <i>bibliometrix</i> package. VOSviewer and CiteSpace were used to visualize collaboration networks and identify major themes and emerging topics. A total of 2,241 eligible articles were included. The United States contributed the highest number of publications (1,428) and total citations (21,190). Imperial College London and the University of Groningen were the top-performing institutions, each contributing 145 publications. The <i>American Journal of Respiratory and Critical Care Medicine</i> was the leading journal by output (128 publications; 8,224 citations), and Barnes PJ was the most influential author by total citations (6,726) and h-index (32). The most frequent keywords were "obstructive pulmonary-disease" (729), "COPD" (418), and "inflammation" (375). Research on neutrophils in COPD has expanded considerably, with airway inflammation remaining a major focus and increasing attention to exacerbations, risk, and mortality. These evolving research themes suggest a growing interest in clinically relevant outcomes. Further studies are needed to determine whether advances in neutrophil-related research can improve clinical risk assessment and treatment strategies.Source: PubMed (PMID: 43061534)View Original on PubMed